http://orcid.org/0000-0002-5873-1602
About the Authors
- Sophia W. Li
-
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
* E-mail: sli140@ucsc.edu
Affiliations Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California, United States of America, Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America
- Meredith Wright
-
Roles Investigation, Methodology
Affiliation Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America
- John F. Healey
-
Roles Formal analysis, Investigation, Methodology, Resources, Validation
Affiliation Department of Pediatrics, Emory University, Atlanta, Georgia, United States of America
- Jennie M. Hutchinson
-
Roles Formal analysis, Investigation, Methodology
Affiliation Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America
- Sara O’Rourke
-
Roles Investigation, Methodology
Affiliation Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America
- Kathryn A. Mesa
-
Roles Investigation
Affiliation Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America
- Pete Lollar
-
Roles Formal analysis, Investigation, Methodology, Supervision, Visualization
Affiliation Department of Pediatrics, Emory University, Atlanta, Georgia, United States of America
- Phillip W. Berman
-
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America
Competing Interests
Sophia W. Li and Phillip W. Berman have filed a patent on C1s‐deficient cells for the production of vaccines and biopharmaceutical proteins. The patent is entitled “Complement Component 1s (C1s) Deficient Cells for Production of Vaccines and Biopharmaceutical Proteins” with publication Number WO/2020/081328. This does not alter our adherence to PLOS ONE policies on sharing data and materials.